文献速递传染病防控与疫情报告免疫规划职业卫生

中国芜湖医护人员在COVID-19疫情头两年百日咳博德特菌感染血清阳性率及特异性抗体水平变化

Seroprevalence of B. pertussis infection and the changes of specific antibody levels in health care workers during the first two years of COVID-19 in Wuhu, China.
PubMed 文献 · Vaccine · 2024-08-22

纳入2021年和2022年在芜湖接受健康体检的762名医护人员,用ELISA检测血清抗PT IgG和IgA。2021年近期百日咳博德特菌感染血清阳性率为10.1%,2022年降至2.4%;2021年77例近期感染者中18例次年抗PT IgG转阴,提示成人百日咳存在未被识别病例且抗体快速消退。

要点

  • 2021年医护人员近期百日咳博德特菌感染血清阳性率为10.1%,2022年降至2.4%。
  • 2021年门诊部医护人员血清阳性率18.6%、GMC 6.3 IU/ml,高于其他部门。
  • 95例百日咳病例中约60.0%无咳嗽病史,38例有咳嗽史者中29例为夜间加重的迁延性咳嗽。

核心结论

  • 医护人员中百日咳博德特菌感染血清阳性率较高,存在未被识别的成人百日咳病例且抗体快速消退,提示需改进成人疑似百日咳的临床管理并在儿童期程序后更新免疫接种程序。

研究设计与样本

  • 纳入2021年和2022年接受健康体检的762名医护人员,采用ELISA检测血清抗PT IgG和IgA水平。
  • 近期百日咳博德特菌感染定义为抗PT IgG ≥100 IU/ml和/或抗PT IgA ≥10 IU/ml。

主要发现

  • 2021年近期百日咳博德特菌感染血清阳性率为10.1%,2022年降至2.4%,差异仍具显著性。
  • 2021年门诊部医护人员血清阳性率18.6%、GMC 6.3 IU/ml,高于其他部门。
  • 2021年77例近期感染者中18例次年抗PT IgG未检出;2021年抗PT IgA ≥10 IU/ml的76例中68例2022年该抗体未检出。
  • 95例百日咳病例中约60.0%无咳嗽病史;有咳嗽记录者中36例疑似百日咳病程但从未被诊断。
  • 有咳嗽史的38例中29例报告夜间加重的迁延性咳嗽,6例确认鸡鸣样回声;3例报告咳嗽发作期间遗尿、1例晕厥,1例出现结膜下出血和紧张性紫癜。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The reported number of pertussis cases declined after the implementation of COVID-19 prevention and control measures, however, the burden of pertussis among adults in China remains largely unknown. Additionally, the waning of natural antibody level has also rarely been assessed. METHODS: A total of 762 healthcare workers (HCWs) who had underwent the health examinations in 2021 and 2022 were included. Serum anti-PT IgG and IgA levels were determined by ELISA. Recent B. pertussis infection was defined as anti-PT IgG ≥100 IU/ml and/or anti-PT IgA ≥10 IU/ml. RESULTS: In 2021, the seroprevalence of recent B. pertussis infection was 10.1 %, and those HCWs in outpatient department had a higher percentage (18.6 %), and geometric mean concentration (GMC) (6.3 IU/ml) than those in other departments. This seroprevalence decreased to 2.4 % in 2022, although the difference remained significant. In the 77 subjects with recent B. pertussis infection in 2021, anti-PT IgG was undetectable in 18 cases the following year. Majority (68/76) of the subjects with anti-PT IgA ≥10 IU/ml in 2021 no longer had detected this antibody in 2022. Among 95 pertussis cases, approximately 60.0 % of cases reported no history of cough. Among those with a documented cough history, 36 cases with suspected pertussis courses who had never been diagnosed. Prolonged cough with nocturnal exacerbation (29/38) was the most commonly reported clinical symptom, and whoop was confirmed in six cases. Uroclepsia and syncopes during the cough attacks were reported by three and one subjects, respectively. One case presented with subconjunctival hemorrhage and tensionic purpura during the course. CONCLUSIONS: The results suggested a high prevalence of B. pertussis infection among HCWs. The presence of unrecognized adult pertussis cases and the rapid waning of antibody indicate the need to improve clinical management for suspected pertussis in adults, and to updated immunization schedule after childhood program.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Meng Q, Wang B, Du Q, et al. Seroprevalence of B. pertussis infection and the changes of specific antibody levels in health care workers during the first two years of COVID-19 in Wuhu, China. Vaccine. 2024. PMID: 39173193. doi:10.1016/j.vaccine.2024.126239

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。